PA Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,718
Closed -$866K 161
2019
Q3
$866K Sell
8,718
-309
-3% -$29.4K 0.85% 43
2019
Q2
$834K Sell
9,027
-809
-8% -$76.8K 0.76% 45
2019
Q1
$928K Buy
+9,836
New +$860K 0.83% 39

Other funds holding CELG

PA Capital's CELG Position: Q4 2019 in Review

PA Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,718 shares — an estimated $866K sold.

PA Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $928K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • PA Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • PA Capital sold 8,718 Celgene Corp shares in Q4 2019, an estimated $866K.
  • PA Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • PA Capital's Celgene Corp position peaked at $928K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on PA Capital's 13F filing for Q4 2019, filed 3 Feb 2020.